AAP
PAHC icon

Arax Advisory Partners’s Phibro Animal Health PAHC Stock Holding History

Arax Advisory Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1K Sell
56
-175
-76% -$8.33K ﹤0.01% 2971
2025
Q4 		$8.63K Sell
231
-283
-55% -$11.5K ﹤0.01% 2546
2025
Q3 		$20.8K Buy
514
+449
+691% +$14.8K ﹤0.01% 2249
2025
Q2 		$1.66K Buy
+65
New +$1.42K ﹤0.01% 2629
2025
Q1 		– Sell
-389
Closed -$8.17K – 2947
2024
Q4 		$8.17K Hold
389
– – ﹤0.01% 1560
2024
Q3 		$8.76K Hold
389
– – ﹤0.01% 1476
2024
Q2 		$6.52K Buy
+389
New +$6.25K ﹤0.01% 1472

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Arax Advisory Partners's PAHC Position: Q1 2026 in Review

Arax Advisory Partners reduced its Phibro Animal Health (PAHC) stake by 76% in Q1 2026, selling an estimated $8.33K and leaving 56 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2971.

Arax Advisory Partners first reported a position in PAHC in Q2 2024 and has held it in 7 quarters since. The position peaked at $20.8K in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Arax Advisory Partners held 56 shares of Phibro Animal Health worth $3.1K as of Q1 2026.
  • Arax Advisory Partners sold 175 Phibro Animal Health shares in Q1 2026, an estimated $8.33K.
  • Phibro Animal Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #2971 holding.
  • Arax Advisory Partners first reported a position in Phibro Animal Health in Q2 2024 and has held it in 7 quarters since.
  • Arax Advisory Partners's Phibro Animal Health position peaked at $20.8K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.